Thus, a PARylation-independent function of CTCF at the LMP1-LMP2 promoter could represent an evolutionary mechanism to ensure PARP1 activation through LMP1 and subsequent epigenetic regulation during EBV infection. The gene discussed is PARP1; the disease is Epstein-Barr virus infection.